99久久99久久精品免费看蜜桃,亚洲国产成人精品青青草原,少妇被粗大的猛烈进出va视频,精品国产不卡一区二区三区,人人人妻人人澡人人爽欧美一区

首頁(yè) > SCI期刊 > 醫(yī)學(xué)期刊 > Advances In Therapy(非官網(wǎng))

Advances In Therapy SCIE

國(guó)際簡(jiǎn)稱(chēng)：ADV THER  參考譯名：治療進(jìn)展

主要研究方向：醫(yī)學(xué)-藥學(xué)  非預(yù)警期刊  審稿周期： 較慢,6-12周

《治療進(jìn)展》(Advances In Therapy)是一本由Springer Healthcare出版的以醫(yī)學(xué)-藥學(xué)為研究特色的國(guó)際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評(píng)論文章和綜述文章，及時(shí)報(bào)道該領(lǐng)域相關(guān)理論、實(shí)踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn)，旨在促進(jìn)該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本未開(kāi)放期刊，近三年沒(méi)有被列入預(yù)警名單。

  • 3區(qū) 中科院分區(qū)
  • Q2 JCR分區(qū)
  • 345 年發(fā)文量
  • 3.4 IF影響因子
  • 未開(kāi)放 是否OA
  • 53 H-index
  • 2000 創(chuàng)刊年份
  • Monthly 出版周期
  • English 出版語(yǔ)言

Advances in Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all therapeutic areas. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged.

The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Advances in Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.

[ 查看全部 ]

Advances In Therapy期刊信息

  • ISSN：0741-238X
  • 出版語(yǔ)言：English
  • 是否OA：未開(kāi)放
  • E-ISSN：1865-8652
  • 出版地區(qū)：ENGLAND
  • 是否預(yù)警：否
  • 出版商：Springer Healthcare
  • 出版周期：Monthly
  • 創(chuàng)刊時(shí)間：2000
  • 開(kāi)源占比：0.6908
  • Gold OA文章占比：68.88%
  • OA被引用占比：0.7717...
  • 出版國(guó)人文章占比：0.07
  • 出版撤稿占比：0
  • 研究類(lèi)文章占比：77.10%

Advances In Therapy CiteScore評(píng)價(jià)數(shù)據(jù)（2024年最新版）

CiteScore SJR SNIP CiteScore 指數(shù)
7.2 1.089 1.316
學(xué)科類(lèi)別 分區(qū) 排名 百分位
大類(lèi)：Medicine 小類(lèi)：Pharmacology (medical) Q1 52 / 272

81%

名詞解釋?zhuān)?/b>CiteScore 是衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個(gè)指標(biāo)。當(dāng)年CiteScore 的計(jì)算依據(jù)是期刊最近4年（含計(jì)算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。例如，2022年的 CiteScore 計(jì)算方法為：2022年的 CiteScore =2019-2022年收到的對(duì)2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻(xiàn)數(shù)量 注：文獻(xiàn)類(lèi)型包括：文章、評(píng)論、會(huì)議論文、書(shū)籍章節(jié)和數(shù)據(jù)論文。

Advances In Therapy中科院評(píng)價(jià)數(shù)據(jù)

中科院 2023年12月升級(jí)版

Top期刊 綜述期刊 大類(lèi)學(xué)科 小類(lèi)學(xué)科
否 否 醫(yī)學(xué) 3區(qū) MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn) PHARMACOLOGY & PHARMACY 藥學(xué) 3區(qū) 3區(qū)

中科院 2022年12月升級(jí)版

Top期刊 綜述期刊 大類(lèi)學(xué)科 小類(lèi)學(xué)科
否 否 醫(yī)學(xué) 3區(qū) MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn) PHARMACOLOGY & PHARMACY 藥學(xué) 3區(qū) 3區(qū)

中科院 2021年12月舊的升級(jí)版

Top期刊 綜述期刊 大類(lèi)學(xué)科 小類(lèi)學(xué)科
否 否 醫(yī)學(xué) 3區(qū) PHARMACOLOGY & PHARMACY 藥學(xué) MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn) 3區(qū) 4區(qū)

中科院 2021年12月基礎(chǔ)版

Top期刊 綜述期刊 大類(lèi)學(xué)科 小類(lèi)學(xué)科
否 否 醫(yī)學(xué) 3區(qū) MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn) PHARMACOLOGY & PHARMACY 藥學(xué) 3區(qū) 3區(qū)

中科院 2021年12月升級(jí)版

Top期刊 綜述期刊 大類(lèi)學(xué)科 小類(lèi)學(xué)科
否 否 醫(yī)學(xué) 3區(qū) PHARMACOLOGY & PHARMACY 藥學(xué) MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn) 3區(qū) 4區(qū)

中科院 2020年12月舊的升級(jí)版

Top期刊 綜述期刊 大類(lèi)學(xué)科 小類(lèi)學(xué)科
否 否 醫(yī)學(xué) 3區(qū) MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學(xué)：研究與實(shí)驗(yàn) PHARMACOLOGY & PHARMACY 藥學(xué) 3區(qū) 3區(qū)

Advances In Therapy JCR評(píng)價(jià)數(shù)據(jù)（2023-2024年最新版）

按JIF指標(biāo)學(xué)科分區(qū) 收錄子集 分區(qū) 排名 百分位
學(xué)科：MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 76 / 189

60.1%
學(xué)科：PHARMACOLOGY & PHARMACY SCIE Q2 105 / 354

70.5%
按JCI指標(biāo)學(xué)科分區(qū) 收錄子集 分區(qū) 排名 百分位
學(xué)科：MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 71 / 189

62.7%
學(xué)科：PHARMACOLOGY & PHARMACY SCIE Q2 130 / 354

63.42%

Advances In Therapy歷年數(shù)據(jù)統(tǒng)計(jì)

影響因子
中科院分區(qū)

Advances In Therapy中國(guó)學(xué)者發(fā)文選摘

  • 1、The Importance of Integrated Regulation Mechanism of Coronary Microvascular Function for Maintaining the Stability of Coronary Microcirculation: An Easily Overlooked Perspective

    Author: Zhu, Houyong; Wang, Hanxin; Zhu, Xinyu; Chen, Qilan; Fang, Xiaojiang; Xu, Xiaoqun; Ping, Yan; Gao, Beibei; Tong, Guoxin; Ding, Yu; Chen, Tielong; Huang, Jinyu

    Journal: ADVANCES IN THERAPY. 2023; Vol. 40, Issue 1, pp. 76-101. DOI: 10.1007/s12325-022-02343-7

  • 2、Peripheral T-reg Levels and Transforming Growth Factor-beta (TGF beta) in Patients with Psoriatic Arthritis: A Systematic Review Meta-Analysis

    Author: Su, Qin-Yi; Zhang, Sheng-Xiao; Yang, Liu; Luo, Jing; Li, Xiao-Feng; Zhang, Jia-Qi; Zhang, Yan; Liu, Jun-Qi; Shi, Lei

    Journal: ADVANCES IN THERAPY. 2023; Vol. 40, Issue 1, pp. 102-116. DOI: 10.1007/s12325-022-02337-5

  • 3、Identification and Validation of a Novel Glycolysis-Related Gene Signature for Predicting the Prognosis and Therapeutic Response in Triple-Negative Breast Cancer

    Author: Zheng, Jian; Zhang, Yi-Fan; Han, Guo-Hui; Fan, Meng-Ying; Du, Ming-Hui; Zhang, Guo-Chen; Zhang, Bo; Qiao, Jun; Zhang, Sheng-Xiao; Cao, Ji-Min

    Journal: ADVANCES IN THERAPY. 2023; Vol. 40, Issue 1, pp. 310-330. DOI: 10.1007/s12325-022-02330-y

  • 4、Recurrence Rates and Pharmacological Treatment for Hemorrhoidal Disease: A Systematic Review

    Author: Lohsiriwat, Varut; Sheikh, Parvez; Bandolon, Robert; Ren, Dong-Lin; Roslani, April Camilla; Schaible, Kassandra; Freitag, Andreas; Martin, Monique; Yaltirik, Pelin; Godeberge, Philippe

    Journal: ADVANCES IN THERAPY. 2023; Vol. 40, Issue 1, pp. 117-132. DOI: 10.1007/s12325-022-02351-7

  • 5、Cost-Effectiveness of Evolocumab in Adult Patients with Atherosclerotic Cardiovascular Disease from Chinese Healthcare Perspective

    Author: Xie, Wenwen; Song, Yinyin; Qin, Xiaomei; Jin, Pengfei

    Journal: ADVANCES IN THERAPY. 2023; Vol. 40, Issue 2, pp. 489-503. DOI: 10.1007/s12325-022-02372-2

  • 6、Quick and Accurate Placement of Cannulated Screws to Internal Fixation of Femoral Neck Fractures Using a Novel Guide Device

    Author: Ren, Bu-fang; Li, Gang; Ma, Quan-ping; Lv, Xin; Sun, Jian

    Journal: ADVANCES IN THERAPY. 2023; Vol. 40, Issue 3, pp. 844-852. DOI: 10.1007/s12325-022-02374-0

  • 7、Efficacy and Safety of PD-1/PD-L1 Inhibitors in Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-analysis

    Author: Liu, Yuwei; Pan, Jiahui; Gao, Fangbo; Xu, Wentao; Li, Hongyu; Qi, Xingshun

    Journal: ADVANCES IN THERAPY. 2023; Vol. 40, Issue 2, pp. 521-549. DOI: 10.1007/s12325-022-02371-3

  • 8、The MODIFY Study Protocol: An Open-Label, Single-Arm, Multicenter, Prospective Pragmatic Study of Ixazomib-Based Triple-Drug Therapy in Chinese Patients with Multiple Myeloma

    Author: Chen, Wenming; Liu, Aijun; Li, Lin

    Journal: ADVANCES IN THERAPY. 2023; Vol. 40, Issue 2, pp. 705-717. DOI: 10.1007/s12325-022-02355-3

免責(zé)聲明

若用戶(hù)需要出版服務(wù)，請(qǐng)聯(lián)系出版商：SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013。